We are live on ! Find out more
ACHC icon

Acadia Healthcare

293 hedge funds and large institutions have $6.43B invested in Acadia Healthcare in 2023 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 87 increasing their positions, 124 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 45 | Existing positions closed: 29

5% more funds holding

Funds holding: 280293 (+13)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

1.98% less ownership

Funds ownership: 101.16%99.18% (-2%)

13% less capital invested

Capital invested by funds: $7.41B → $6.43B (-$982M)

30% less repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 124

38% less call options, than puts

Call options by funds: $6.13M | Put options by funds: $9.85M

Holders
293
Holders Change
+13
Holders Change %
+4.64%
% of All Funds
4.65%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.1%
New
45
Increased
87
Reduced
124
Closed
29
Calls
$6.13M
Puts
$9.85M
Net Calls
-$3.72M
Net Calls Change
-$7.88M
Name Holding Trade Value Shares
Change
Change in
Stake
SI
201
Stephens Inc
Arkansas
$368K -$32.3K -432 -8%
Qube Research & Technologies (QRT)
202
Qube Research & Technologies (QRT)
United Kingdom
$367K -$400K -5,349 -51%
CCM
203
Coldstream Capital Management
Washington
$360K +$6.43K +86 +2%
ProShare Advisors
204
ProShare Advisors
Maryland
$358K -$30.6K -410 -7%
Envestnet Portfolio Solutions
205
Envestnet Portfolio Solutions
Illinois
$355K +$377K +5,042 New
SCM
206
Shelton Capital Management
Colorado
$347K
URS
207
Utah Retirement Systems
Utah
$345K +$7.47K +100 +2%
PCM
208
Prelude Capital Management
New York
$342K +$364K +4,870 New
KI
209
Kapitalo Investimentos
Brazil
$340K +$362K +4,840 New
FA
210
FDx Advisors
Illinois
$339K -$207K -2,769 -37%
KeyBank National Association
211
KeyBank National Association
Ohio
$338K -$51K -682 -12%
PAS
212
Park Avenue Securities
New York
$316K +$336K +4,498 New
LI
213
Latash Investments
Alaska
$315K
II
214
Inspire Investing
Idaho
$307K +$31.4K +420 +11%
SAM
215
Shell Asset Management
Netherlands
$304K -$5.08K -68 -2%
CAM
216
Cresset Asset Management
Illinois
$301K +$41.8K +560 +15%
RFC
217
Regions Financial Corp
Alabama
$291K -$4.71K -63 -1%
Verition Fund Management
218
Verition Fund Management
Connecticut
$291K +$309K +4,138 New
QCM
219
QRG Capital Management
Illinois
$287K +$305K +4,082 New
HighTower Advisors
220
HighTower Advisors
Illinois
$286K +$302K +4,047 New
PAM
221
Panagora Asset Management
Massachusetts
$277K
AIM
222
Aigen Investment Management
New York
$276K +$293K +3,925 New
Lazard Asset Management
223
Lazard Asset Management
New York
$265K +$266K +3,554 +1,594%
QC
224
Quent Capital
New York
$244K +$747 +10 +0.3%
Wealth Enhancement Advisory Services
225
Wealth Enhancement Advisory Services
Minnesota
$242K +$257K +3,446 New

ACHC Hedge Fund Activity: Q3 2023 in Review

293 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Acadia Healthcare (ACHC) for Q3 2023, worth a combined $6.43B — down 13% from $7.41B a quarter earlier.

Buyers outnumbered sellers: 45 funds opened new ACHC positions and 29 closed out — a net gain of 16 holders — while 87 added to existing stakes and 124 trimmed.

The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $23.6M. The largest seller was Viking Global Investors, cutting an estimated $73.6M.

  • 293 institutional investors held Acadia Healthcare (ACHC) as of Q3 2023, up from 280 in Q2 2023.
  • Funds reported $6.43B of Acadia Healthcare stock for Q3 2023, down 13% quarter-over-quarter.
  • 45 funds opened new Acadia Healthcare positions in Q3 2023 and 29 closed out, a net change of +16 holders.
  • The largest Acadia Healthcare buyer in Q3 2023 was Balyasny Asset Management, an estimated $23.6M added.
  • The largest Acadia Healthcare seller in Q3 2023 was Viking Global Investors, an estimated $73.6M sold.

Based on aggregated 13F filings for Q3 2023.